当前位置:首页 - 行情中心 - 凯普生物(300639) - 财务分析

凯普生物

(300639)

  

流通市值:35.57亿  总市值:36.20亿
流通股本:6.35亿   总股本:6.47亿

凯普生物(300639)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润-0.44亿元,每股收益-0.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益393962.35万元,未分配利润243587.77万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产453445.84万元,负债59483.49万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入134,063,936.62815,528,791.93610,244,080.75408,884,662.9
营业总成本170,514,212.191,006,571,895.71678,692,168.29476,911,703.15
营业利润-41,203,376.46-821,719,246.95-456,826,666.67-131,398,882.53
利润总额-44,776,020.11-832,967,354.03-460,461,323.36-132,901,323.39
净利润-44,364,773.76-950,350,169.79-400,719,206.84-129,351,655.63
其他综合收益-3,341,950.914,588,473.21-6,565,547.689,718,312.43
综合收益总额-47,706,724.67-945,761,696.58-407,284,754.52-119,633,343.2
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计2,164,935,866.82,225,642,938.292,494,553,729.992,840,582,138.51
非流动资产合计2,369,522,492.462,397,342,362.422,599,076,132.592,582,427,105.8
资产总计4,534,458,359.264,622,985,300.715,093,629,862.585,423,009,244.31
流动负债合计417,238,011.11441,546,426.82380,924,726.01387,951,689.14
非流动负债合计177,596,873.32134,890,725.85130,510,053.35138,225,817.85
负债合计594,834,884.43576,437,152.67511,434,779.36526,177,506.99
归属于母公司股东权益合计4,020,976,372.394,109,445,878.464,488,450,785.394,716,694,716.41
股东权益合计3,939,623,474.834,046,548,148.044,582,195,083.224,896,831,737.32
负债和股东权益合计4,534,458,359.264,622,985,300.715,093,629,862.585,423,009,244.31
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计242,012,435.441,075,523,993.97804,799,817.14518,334,838.95
经营活动现金流出小计195,094,437.94996,745,542.46760,410,406.43551,558,967.2
经营活动产生的现金流量净额46,917,997.578,778,451.5144,389,410.71-33,224,128.25
投资活动现金流入小计116,878,124.1694,813,057.8583,419,092.1422,057,147.09
投资活动现金流出小计131,892,794.73805,162,794.48415,471,385.2388,416,934.84
投资活动产生的现金流量净额-15,014,670.63-110,349,736.68167,947,706.933,640,212.25
筹资活动现金流入小计53,000,00055,318,59255,318,59225,000,000
筹资活动现金流出小计68,698,079.08130,587,142.05121,505,964.383,238,386.36
筹资活动产生的现金流量净额-15,698,079.08-75,268,550.05-66,187,372.3-58,238,386.36
汇率变动对现金及现金等价物的影响-1,261,977.637,587,913.7-1,615,182.435,955,834.18
现金及现金等价物净增加额14,943,270.16-99,251,921.52144,534,562.88-51,866,468.18
期末现金及现金等价物余额687,161,663.31662,115,776.09905,902,260.49709,501,229.43
TOP↑